SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-135381
Filing Date
2016-11-18
Accepted
2016-11-18 16:00:54
Documents
2
Period of Report
2016-12-22
Effectiveness Date
2016-11-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT v453311_def14a.htm DEF 14A 153613
2 GRAPHIC arno_logo.jpg GRAPHIC 8393
  Complete submission text file 0001144204-16-135381.txt   166461
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

IRS No.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-52153 | Film No.: 162007802
SIC: 2834 Pharmaceutical Preparations